Oxalosis and Hyperoxaluria Foundation (OHF) - Home




We Are The OHF
The OHF is made up of a resourceful staff, a committed Board of Directors and an esteemed Scientific Advisory Board of top experts from around the globe. In addition, volunteers from all walks of life give generously of their time and talents to help the OHF make a difference.

Office Staff
Board of Directors
National Advisory Board
Scientific Advisory Board Members
Scientific Advisory Council

Office Staff
The efforts of the OHF are coordinated by a professional staff and is headquartered in New York, New York.

Kim Hollander, Executive Director
New York, New York
kimh@ohf.org, 212.777.0470

Julie Bertarelli, Mid-West Coordinator
St. Louis, Missouri
julieb@ohf.org

OHF Board Of Directors
Our voluntary Board of Directors oversees the OHF. The Board is comprised of parents, doctors, researchers and business people from across the country.

Officers

Brett Rosen, President
New York, New York
CPA, Senior Managing Director, Cowan Financial Group, LLC


Tim Berra, Vice President
St. Louis, Missouri
President, Heidtman Steel


Debra Wattenberg, M.D., Vice President of Scientific and Medical Affairs
New York, New York
Dermatology Practice


Donald L. Ashkenase, Treasurer
Great Neck, New York
Executive Vice President - Corporate
Montefiore Medical Center


Lisa Berra, Secretary
St. Louis, Missouri


Members

Bernd Hoppe, M.D.
University Children's Hospital
Kinderdialyse
Josef-Stelzman Str. 9
D-50924 Cologne, Germany

Craig B. Langman, M.D., Medical Editor
Chicago, Illinois
Isaac A. Abt, MD Professor of Kidney Diseases
Feinberg School of Medicine, Northwestern University
Head, Kidney Diseases, Childrens Memorial Medical Center

Allen M. Spiegel, M.D.
Bronx, New York
Dean, Albert Einstein College of Medicine

OHF National Advisory Board

Donny Deutsch
New York, New York
President, Deutsch, Inc.

Craig and Caryn Effron
New York, New York

Harvey M. Schwartz
New York, New York
Managing Director, Partner
Goldman Sachs

Scientific Advisory Board
The Scientific Advisory Board (SAB) provides advice, as well as medical and scientific expertise to the OHF on an ongoing basis. The SAB is regularly informed of the progress of OHF research and development projects and provides feedback and ideas intended to accelerate the development process. The SAB also fulfills the role of external advisors involved in project-specific reviews and enhances the OHF's innovation process by providing support to the OHF scientific and medical community. Members of the SAB volunteer their time, individual knowledge and expertise to help broaden the scope, content, health and balance of related issues.


Marguerite Hatch, Ph.D., Chairperson
The University of Florida
Department of Pathology
College of Medicine, Box 100275
Gainesville, Florida 32610-0275
[bio]
 
John Asplin, M.D.
University of Chicago
Section of Nephrology
MC5100
5841 S. Maryland Avenue
Chicago, Illinois 60637
[bio]
 
Chris Danpure, B.Sc. Ph.D.
Department of Biology
University College London
Gower Street
London, WC1E6B United Kingdom
[bio]
 
Jaap Groothoof, MD, PhD
Pediatric Nephrology
Emma Children’s Hospital Academic Medical Center
Amsterdam, Netherlands
 

Dawn Milliner, M.D.
Mayo Clinic
200 First Street
Rochester, Minnesota 55005
[bio]
 
Ross Holmes, Ph.D.
Department of Urology
Wake Forest School of Medicine
Medical Center Boulevard
Winston-Salem, NC 27157
 
Saeed Khan, Ph.D.
Department of Pathology
1600 SW Archer Road
P.O. Box 100275
Gainesville, Florida 32610-0275
[bio]
 

Scientific Advisory Council
The Scientific Advisory Council (SAC), comprised of specialists and experts in related fields, provides independent advice as needed to the Scientific Advisory Board (SAB) on matters of concern in the fields of Oxalosis, PH and related stone diseases. The SAC may also review the Foundation's research portfolio and identify promising new areas of research.


Dean G. Assimos, MD
Professor of Surgical Sciences
Department of Urology
Wake Forest University School of Medicine
 
Pierre Cochat, MD
Département de Pédiatrie & Inserm U499
Hôpital Edouard-Herriot & Université Claude-Bernard
 
Jayanta Roy-Chowdhury, MD
Professor of Medicine and Molecular Genetics
Albert Einstein College of Medicine
 
Scott Cramer, PhD
Associate Professor
Department of Cancer Biology
Wake Forest University School of Medicine
 
John Herrin, MD
Division of Nephrology
Children's Hospital Hun 3
 
Julie A. Jonassen, PhD
Associate Professor
University of Massachusetts Medical School
Department of Physiology
 
Markus Kemper, MD
Universitätsklinik f. Kinderheilkunde
U. Jugendmedizin
 
Hari K Koul, MSc, PhD, FACN
Professor and Director of Research,
Department of Surgery-Division of Urology
School of Medicine,
University of Colorado Health Sciences Center
 

Kay Latta, MD
Clementine-Kinderhospital
 
John Lieske, PhD
Division of Nephrology
Mayo Clinic
 
Robert B. Miller, MD
Albuquerque, New Mexico
 
Carla Monico, MD
Division of Nephrology
Mayo Clinic
 
Helen O'Connor, MS RD CCRP
General Clinic Research Center
Mayo Clinic College of Medicine
 
Craig Peters, MD
Department of Urology
Children's Hospital Boston
Harvard Medical School
 
Edward Purdue, PhD
Department of Biology
Mount Sinai School of Medicine
 
William Robertson, PhD
Institute of Urology/Nephrology
University College London
 
Gill Rumsby, PhD FRCPath
Consultant Biochemist
Clinical Biochemistry UCL Hospitals
 
Rosemary Ryall, PhD, DSc
Department of Surgery
Flinders Medical Center
 
Eduardo Salido, MD
Professor, Department of Pathology
Hospital Universitario 1
Universidad La Laguna
 
Jon Scheinman, MD
Chief, Pediatric Nephrology Section
University of Kansas
 
 




The OHF is a 501 (c)(3), public charity.
© Oxalosis & Hyperoxaluria Foundation (OHF) · Legal Disclaimer

For problems with this website please email webmaster@ohf.org

Website design ©1996 - 2008 Relevant Arts